Survey: Cancer Patients Seek 10-Day Treatment Leave; Tax Cuts Urged to Foster Friendly Workplaces

Key facts

  • Survey: Cancer Patients Seek 10-Day Treatment Leave; Tax Cuts Urged to Foster Friendly Workplaces
  • A survey of over 1,000 cancer patients in Taiwan reveals that over 50% need to work but struggle to balance treatment. Respondents are calling for 10 days of specialized treatment leave and tax incentives for companies to support a 'Cancer-Friendly Workplace.'
  • Source: PR Times
  • Date: April 28, 2026

Direct answer

A survey of over 1,000 cancer patients in Taiwan reveals that over 50% need to work but struggle to balance treatment. Respondents are calling for 10 days of specialized treatment leave and tax incentives for companies to support a 'Cancer-Friendly Workplace.'

Citation
Survey: Cancer Patients Seek 10-Day Treatment Leave; Tax Cuts Urged to Foster Friendly Workplaces (April 28, 2026), PR Times
Source
PR Times
Date
April 28, 2026
A survey of over 1,000 cancer patients in Taiwan reveals that over 50% need to work but struggle to balance treatment. Respondents are calling for 10 days of specialized treatment leave and tax incentives for companies to support a 'Cancer-Friendly Workplace.'
調査NQ 0/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: April 28, 2026 at 18:16
  • 🔍 Collected: April 28, 2026 at 18:32 (15 min after Published)
  • 🤖 AI Analyzed: April 28, 2026 at 20:06 (1h 34m after Collected)
(CNA, Taipei, 28th) A survey has pointed out that over half of cancer patients in Taiwan have a need to work, but find it difficult to balance treatment and employment. They are calling for an annual addition of 10 days of cancer treatment leave. 92.7% of patients believe that through tax reductions or subsidies, it would help promote 'Cancer-Friendly Workplaces' among enterprises. The Taiwan Breast Cancer Alliance announced the results of the 'Public Opinion Survey on Employment Needs of Cancer Patients' today. The survey targeted patients nationwide who were employed at the time of their diagnosis. Conducted online from March 13 to 31, it collected 1,068 samples with a margin of error of +/- 2.99% at a 95% confidence level. The subjects were 86.1% female and 13.9% male; 74.3% were breast cancer patients. Most were in stages 1 or 2, with nearly 50% having completed primary treatment and currently under follow-up. The largest age group was 40-49 years old. While 86% were full-time at the time of diagnosis, that has dropped to 62.6% now. Findings show 63.9% continue working due to economic necessity. 'Difficulty taking leave affecting treatment' is a major external factor for resignation. Nearly 84% need leave for treatment, but 46.1% have difficulty obtaining it. 92% believe treatment affects work, but only 28.8% received workload or hour reductions. Notably, over 30% hope for '10 extra days of treatment leave.' Over 90% support adjusted roles with productivity-based pay. 95.2% agree HR personnel should receive 'Cancer-Friendly Workplace Training.' Legislator Wang Cheng-hsu called for amending the 'Cancer Prevention Act' to include labor rights. Legislator Chen Ching-hui highlighted the higher need for working while treating due to singlehood and low birth rates, urging tax subsidies for flexible work. Alliance Chairperson Huang Shu-fang urged establishing friendly leave mechanisms so leave doesn't become a barrier to treatment.

FAQ

What are the key facts in this article?

A survey of over 1,000 cancer patients in Taiwan reveals that over 50% need to work but struggle to balance treatment. Respondents are calling for 10 days of specialized treatment leave and tax incentives for companies to support a 'Cancer-Friendly Workplace.'

What is the direct answer?

A survey of over 1,000 cancer patients in Taiwan reveals that over 50% need to work but struggle to balance treatment. Respondents are calling for 10 days of specialized treatment leave and tax incentives for companies to support a 'Cancer-Friendly Workplace.'

What is the source and date?

PR Times: https://www.cna.com.tw/news/ahel/202604280262.aspx | April 28, 2026